Cargando…

The impact of Alzheimer’s disease risk factors on the pupillary light response

Alzheimer’s disease (AD) is the leading cause of dementia, and its prevalence is increasing and is expected to continue to increase over the next few decades. Because of this, there is an urgent requirement to determine a way to diagnose the disease, and to target interventions to delay and ideally...

Descripción completa

Detalles Bibliográficos
Autores principales: Sparks, Sierra, Pinto, Joana, Hayes, Genevieve, Spitschan, Manuel, Bulte, Daniel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463762/
https://www.ncbi.nlm.nih.gov/pubmed/37650103
http://dx.doi.org/10.3389/fnins.2023.1248640
_version_ 1785098308393369600
author Sparks, Sierra
Pinto, Joana
Hayes, Genevieve
Spitschan, Manuel
Bulte, Daniel P.
author_facet Sparks, Sierra
Pinto, Joana
Hayes, Genevieve
Spitschan, Manuel
Bulte, Daniel P.
author_sort Sparks, Sierra
collection PubMed
description Alzheimer’s disease (AD) is the leading cause of dementia, and its prevalence is increasing and is expected to continue to increase over the next few decades. Because of this, there is an urgent requirement to determine a way to diagnose the disease, and to target interventions to delay and ideally stop the onset of symptoms, specifically those impacting cognition and daily livelihood. The pupillary light response (PLR) is controlled by the sympathetic and parasympathetic branches of the autonomic nervous system, and impairments to the pupillary light response (PLR) have been related to AD. However, most of these studies that assess the PLR occur in patients who have already been diagnosed with AD, rather than those who are at a higher risk for the disease but without a diagnosis. Determining whether the PLR is similarly impaired in subjects before an AD diagnosis is made and before cognitive symptoms of the disease begin, is an important step before using the PLR as a diagnostic tool. Specifically, identifying whether the PLR is impaired in specific at-risk groups, considering both genetic and non-genetic risk factors, is imperative. It is possible that the PLR may be impaired in association with some risk factors but not others, potentially indicating different pathways to neurodegeneration that could be distinguished using PLR. In this work, we review the most common genetic and lifestyle-based risk factors for AD and identify established relationships between these risk factors and the PLR. The evidence here shows that many AD risk factors, including traumatic brain injury, ocular and intracranial hypertension, alcohol consumption, depression, and diabetes, are directly related to changes in the PLR. Other risk factors currently lack sufficient literature to make any conclusions relating directly to the PLR but have shown links to impairments in the parasympathetic nervous system; further research should be conducted in these risk factors and their relation to the PLR.
format Online
Article
Text
id pubmed-10463762
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104637622023-08-30 The impact of Alzheimer’s disease risk factors on the pupillary light response Sparks, Sierra Pinto, Joana Hayes, Genevieve Spitschan, Manuel Bulte, Daniel P. Front Neurosci Neuroscience Alzheimer’s disease (AD) is the leading cause of dementia, and its prevalence is increasing and is expected to continue to increase over the next few decades. Because of this, there is an urgent requirement to determine a way to diagnose the disease, and to target interventions to delay and ideally stop the onset of symptoms, specifically those impacting cognition and daily livelihood. The pupillary light response (PLR) is controlled by the sympathetic and parasympathetic branches of the autonomic nervous system, and impairments to the pupillary light response (PLR) have been related to AD. However, most of these studies that assess the PLR occur in patients who have already been diagnosed with AD, rather than those who are at a higher risk for the disease but without a diagnosis. Determining whether the PLR is similarly impaired in subjects before an AD diagnosis is made and before cognitive symptoms of the disease begin, is an important step before using the PLR as a diagnostic tool. Specifically, identifying whether the PLR is impaired in specific at-risk groups, considering both genetic and non-genetic risk factors, is imperative. It is possible that the PLR may be impaired in association with some risk factors but not others, potentially indicating different pathways to neurodegeneration that could be distinguished using PLR. In this work, we review the most common genetic and lifestyle-based risk factors for AD and identify established relationships between these risk factors and the PLR. The evidence here shows that many AD risk factors, including traumatic brain injury, ocular and intracranial hypertension, alcohol consumption, depression, and diabetes, are directly related to changes in the PLR. Other risk factors currently lack sufficient literature to make any conclusions relating directly to the PLR but have shown links to impairments in the parasympathetic nervous system; further research should be conducted in these risk factors and their relation to the PLR. Frontiers Media S.A. 2023-08-15 /pmc/articles/PMC10463762/ /pubmed/37650103 http://dx.doi.org/10.3389/fnins.2023.1248640 Text en Copyright © 2023 Sparks, Pinto, Hayes, Spitschan and Bulte. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Sparks, Sierra
Pinto, Joana
Hayes, Genevieve
Spitschan, Manuel
Bulte, Daniel P.
The impact of Alzheimer’s disease risk factors on the pupillary light response
title The impact of Alzheimer’s disease risk factors on the pupillary light response
title_full The impact of Alzheimer’s disease risk factors on the pupillary light response
title_fullStr The impact of Alzheimer’s disease risk factors on the pupillary light response
title_full_unstemmed The impact of Alzheimer’s disease risk factors on the pupillary light response
title_short The impact of Alzheimer’s disease risk factors on the pupillary light response
title_sort impact of alzheimer’s disease risk factors on the pupillary light response
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463762/
https://www.ncbi.nlm.nih.gov/pubmed/37650103
http://dx.doi.org/10.3389/fnins.2023.1248640
work_keys_str_mv AT sparkssierra theimpactofalzheimersdiseaseriskfactorsonthepupillarylightresponse
AT pintojoana theimpactofalzheimersdiseaseriskfactorsonthepupillarylightresponse
AT hayesgenevieve theimpactofalzheimersdiseaseriskfactorsonthepupillarylightresponse
AT spitschanmanuel theimpactofalzheimersdiseaseriskfactorsonthepupillarylightresponse
AT bultedanielp theimpactofalzheimersdiseaseriskfactorsonthepupillarylightresponse
AT sparkssierra impactofalzheimersdiseaseriskfactorsonthepupillarylightresponse
AT pintojoana impactofalzheimersdiseaseriskfactorsonthepupillarylightresponse
AT hayesgenevieve impactofalzheimersdiseaseriskfactorsonthepupillarylightresponse
AT spitschanmanuel impactofalzheimersdiseaseriskfactorsonthepupillarylightresponse
AT bultedanielp impactofalzheimersdiseaseriskfactorsonthepupillarylightresponse